|Catalog||Size (Price)||Quantity||In Stock||Operation||Other Information|
CD22 Antibody Datasheet
|Order or Inquire for CD22 Antibody product||Quality antibodies||Antibody production services|
CD22 Antibody Product Information
Recombinant Human CD22 protein (Catalog#11958-H08H)
|Reagents :||FITC-conjugated mouse monoclonal antibody|
Clone ID :
|Ig Type :||
10 μl/Test, 0.1 mg/ml
|Formulation :||Aqueous solution containing 0.5% BSA and 0.09% sodium azide|
This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human CD22 (rh CD22; Catalog#11958-H08H; P20273-1; Met 1-Arg 687) and conjugated with FITC under optimum conditions, the unreacted FITC was removed.
CD22 Antibody Usage Guide
|Flow Cytometry :||
Profile of anti-CD22 reactivity on Daudi cells analyzed by flow cytometry. Cells should be Fc-blocked by treatment with 20 μg of human IgG/106 cells for 1 hour at 4 ℃ prior to staining, washed, then stained with FITC Mouse anti-CD22.Flow cytometry was performed on a BD FACSCalibur flow cytometry system
Please refer to www.sinobiological.com/Flow-Cytometry-FACS-Protocols-a-750.html for technical protocols.
|Storage :||This antibody is stable for 12 months from date of receipt when stored at 2℃- 8℃. Protected from prolonged exposure to light. Do not freeze !
Sodium azide is toxic to cells and should be disposed of properly. Flush with large volumes of water during disposal.
CD22 Antibody Related Products & Topics
CD22 Antibody Related Areas:
|Molecule||Species||Description //For Detailed Info. and Price------CLICK!||Cat. No|
|CD22||Human||CD22 Protein, Recombinant||11958-H08H|
|Molecule||Application||Description //For Detailed Info. and Price------CLICK!||Cat. No|
|Human CD22||FCM||CD22 Antibody ( FITC )||11958-MM05-F|
|Human CD22||ELISA||CD22 Antibody||11958-MM07|
CD22 Antibody Background
- Sato S. et al., 1998, Semin Immunol. 10 (4): 287-97.
- Walker JA. et al., 2008, Immunology. 123 (3): 314-25.
- Nitschke L. 2009, Immunol Rev. 230 (1): 128-43.
- Tedder TF. et al., 2005, Adv Immunol. 88: 1-50.
- Fujimoto M. et al., 2007, J Dermatol Sci. 46 (1): 1-9.